| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/20/2001 | WO2001096371A2 Adipose-related gene |
| 12/20/2001 | WO2001096370A2 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 12/20/2001 | WO2001096363A1 Fatty acid desaturase gene and protein for modulating activation of defense signaling pathways in plants |
| 12/20/2001 | WO2001096362A1 A novel peptide --- human phosphatidase 16 and the polynucleotide coding this novel peptide |
| 12/20/2001 | WO2001096360A1 Antisense modulation of c/ebp beta expression |
| 12/20/2001 | WO2001096356A1 Antisense molecules and method of controlling expression of gene function by using the same |
| 12/20/2001 | WO2001096354A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues |
| 12/20/2001 | WO2001096351A1 Inhibiting denaturation of nucleic acid duplexes |
| 12/20/2001 | WO2001096023A2 Dielectrically-engineered microparticles |
| 12/20/2001 | WO2001095933A2 Immunization through oral administration of a vaccine with an edible product |
| 12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 12/20/2001 | WO2001095860A2 Probes for chondrogenesis |
| 12/20/2001 | WO2001095855A2 Pregnancy-associated plasma protein-e (papp-e) |
| 12/20/2001 | WO2001095815A1 Integrated herd management system utilizing isolated populations of x-chromosome bearing and y-chromosome bearing spermatozoa |
| 12/20/2001 | WO2001095724A2 Methods of improving the effectiveness of transgenic plants |
| 12/20/2001 | WO2001095711A2 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | WO2001095710A1 Caspase 1 gene transfer animal |
| 12/20/2001 | WO2001095709A1 Mouse showing neurofibril change due to senile dementia |
| 12/20/2001 | WO2001095708A1 Vitamin d receptor-deficient cell line |
| 12/20/2001 | WO2001095702A1 Modification of lignin biosynthesis |
| 12/20/2001 | WO2001095701A2 Methods for somatic embryo formation and plant regeneration of beta vulgaris |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001079259A8 Javelinization of protein antigens to heat shock proteins |
| 12/20/2001 | WO2001076620A3 Use of vegf and homologues to treat neuron disorders |
| 12/20/2001 | WO2001064751A3 High potency recombinant antibodies and method for producing them |
| 12/20/2001 | WO2001062953A3 Electrochemical method for detecting nucleic acids |
| 12/20/2001 | WO2001062941A3 Regulation of human gelatinase b-like enzyme 2 |
| 12/20/2001 | WO2001062933A3 Muteins of interleukin-13 (il-13) |
| 12/20/2001 | WO2001062207A3 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 12/20/2001 | WO2001059128A3 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 12/20/2001 | WO2001059100A3 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 12/20/2001 | WO2001059091A3 Multi-gene expression constructs containing modified inteins |
| 12/20/2001 | WO2001057274A8 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart |
| 12/20/2001 | WO2001055428A3 Mprot45 metalloprotease |
| 12/20/2001 | WO2001055367A8 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001055306A3 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001055303A3 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001054719A3 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 12/20/2001 | WO2001054474A8 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001053531A3 Osteoarthritis tissue derived nucleic acids, polypeptides, vectors, and cells |
| 12/20/2001 | WO2001053518A3 Method of assessing the viability of a cell |
| 12/20/2001 | WO2001053470A3 Nucleic acid and amino acid sequences encoding a de novo dna methyltransferase |
| 12/20/2001 | WO2001052874A3 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 12/20/2001 | WO2001051640A3 Regulation of human mitochondrial transformylase |
| 12/20/2001 | WO2001051601A3 Methods for the storage and synthesis of nucleic acids |
| 12/20/2001 | WO2001051045A3 Modulators of the constitutive adrostane receptor (car): screening and treatment of hypercholesterolemia |
| 12/20/2001 | WO2001051006A3 Cardiac-cell specific enhancer elements and uses thereof |
| 12/20/2001 | WO2001048208A3 Streptococcus pyogenes virulence genes and proteins and their use |
| 12/20/2001 | WO2001044809A3 Evaluation of biological agents in living target cells |
| 12/20/2001 | WO2001044454A3 Root-specific promoter |
| 12/20/2001 | WO2001044292A3 Wasp (wiskott-aldrich syndrome protein) family protein fragments, and use thereof |
| 12/20/2001 | WO2001038568A3 Automated method for identifying related biomolecular sequences |
| 12/20/2001 | WO2001034292A3 Macroporous media for biological application prepared by freeze drying |
| 12/20/2001 | WO2001031055A3 Method and kit for the screening and/or the quantification of multiple homologous nucleic acid sequences on arrays |
| 12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
| 12/20/2001 | WO2001029207A8 Antiuracil monoclonal antibody |
| 12/20/2001 | WO2001025457A3 Gmp synthetase derived from plants |
| 12/20/2001 | WO2001023592A3 Methods for making recombinant proteins using apoptosis inhibitors |
| 12/20/2001 | WO2001002552A3 Double transgenic animals as models for neurodegenerative disease |
| 12/20/2001 | WO2000068387A3 Nucleic acids and proteins with interferon-beta activity |
| 12/20/2001 | WO2000066780A3 Adeno-associated virus-delivered ribozyme compositions and methods of use |
| 12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 12/20/2001 | WO2000058358A9 49 human secreted proteins |
| 12/20/2001 | WO2000024765A8 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/20/2001 | WO2000020593A9 Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and uses thereof |
| 12/20/2001 | WO2000017103A9 Inventory control |
| 12/20/2001 | WO2000008133A9 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 12/20/2001 | WO1999028506A3 Cancer susceptibility mutations of brca2 |
| 12/20/2001 | WO1995026406A3 Riboflavin synthesis in fungi |
| 12/20/2001 | US20010054186 An improved efficiency agrobacterium-mediated plant transformation method |
| 12/20/2001 | US20010054185 Transgenic mouse embryo; for use as a model in the treatment of drug abuse |
| 12/20/2001 | US20010053848 Reaction product of protein g and receptor |
| 12/20/2001 | US20010053847 Bioproduction of para-hydroxycinnamic acid |
| 12/20/2001 | US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/20/2001 | US20010053768 Gene therapy using replication competent targeted adenoviral vectors |
| 12/20/2001 | US20010053761 Method for administering aspb28-human insulin |
| 12/20/2001 | US20010053550 Cloning embryos |
| 12/20/2001 | US20010053544 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
| 12/20/2001 | US20010053540 Forming biocompatible label; provide nucleotide sequences, denature, attach compound which prevents crystalization, monitor denatured nucleotide sequences |
| 12/20/2001 | US20010053538 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053533 Detecting infectious protein in solution; prepare solution composed from body fluid or fluidized organ expose to chromatographic column, detect infectious protein |
| 12/20/2001 | US20010053532 Detecting agonist or antagonist of binding protein; incubation of agonist/antagonist with binding protein, monitor response from binding protein |
| 12/20/2001 | US20010053527 Arrays with mask layers and methods of manufacturing same |
| 12/20/2001 | US20010053524 Cell libraries indexed to nucleic acid microarrays |
| 12/20/2001 | US20010053523 Method for identification of biologically active peptides and nucleic acids |
| 12/20/2001 | US20010053516 Computer method and system for correlating data |
| 12/20/2001 | US20010053497 Arrays with mask layers and methods of manufacturing same |
| 12/20/2001 | US20010053367 Vaccines expressed in plants |
| 12/20/2001 | US20010053358 Growth differentiation factor-11 |
| 12/20/2001 | US20010053352 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 12/20/2001 | US20010053334 Microarray fabrication techniques and apparatus |
| 12/20/2001 | DE10120829A1 Gene transfer method, useful in therapy, diagnosis and preparing transgenic animals, uses both components of the Sleeping Beauty transfer system |
| 12/20/2001 | DE10115761A1 Preparing transgenic monocotyledonous plants for producing cereals, comprises timing the stages for optimal proliferative and regenerative capacity without use of marker DNA |
| 12/20/2001 | DE10028901A1 New human gene hEDG-8 encoding G-protein coupled receptor, useful for developing treatments and diagnoses for e.g. multiple sclerosis |
| 12/20/2001 | DE10028837A1 Detecting infection by influenza A or B virus, comprises rapid analysis of a saliva sample, with detection of nucleic acid or nucleoprotein |
| 12/20/2001 | DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
| 12/20/2001 | CA2804117A1 Method for modifying plant morphology, biochemistry and physiology |
| 12/20/2001 | CA2736957A1 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |